The Evolution of GLP-1 Medication Access: Navigating the American Retail and Telehealth LandscapeOver the last few years, the pharmaceutical landscape in America has been basically changed by the emergence and escalating appeal of GLP-1 (Glucagon-like peptide-1) receptor agonists. Originally established to handle Type 2 diabetes, these medications-- consisting of family
